Form 4 for KVYO Klaviyo, Inc.
Accepted 2026-03-19 00:00:00 ET · period of report 2026-03-17 · accession 0001470831-26-000299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-19 | 2026-03-17 | KVYO | Bialecki Andrew | Co-CEO, Dir, 10% | C - Cnv Deriv | — | +200.0K | 200.0K | New | — |
| DM | 2026-03-19 | 2026-03-17 | KVYO | Bialecki Andrew | Co-CEO, Dir, 10% | S - Sale | $19.37 | -200.0K | 102.6K | -66% | -$3.87M |
| D | 2026-03-19 | 2026-03-17 | KVYO | Bialecki Andrew | Co-CEO, Dir, 10% | C - Cnv Deriv | $0.00 | -200.0K | 68.14M | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2026-03-17 | C | A | 200,000 | — | 200,000 | D | — | — | (F2) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 2 | Common | Series A Common Stock | 2026-03-17 | S | D | 102,621 | $19.15 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.10 to $19.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Series A Common Stock | 2026-03-17 | S | D | 97,379 | $19.60 | 102,621 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.33 to $20.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Series B Common Stock | 2026-03-17 | C | D | 200,000 | $0.00 | 68,144,118 | D | — · — to — | 200,000 Series A Common Stock | (F2) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |